Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.

about

Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.

Item

http://www.wikidata.org/entity/Q50051683

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.

@en

Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.

@nl

type

Item

label

Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.

@en

Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.

@nl

prefLabel

Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.

@en

Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.

@nl

P1476

Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.

@en

P2093

Andrew J King

http://www.w3.org/2001/XMLSchema#string

James P Davidson

http://www.w3.org/2001/XMLSchema#string

Jeffrey W Jacobs

http://www.w3.org/2001/XMLSchema#string

Jeremy S Caldwell

http://www.w3.org/2001/XMLSchema#string

Padmapriya Kumaraswamy

http://www.w3.org/2001/XMLSchema#string

Paul Korner

http://www.w3.org/2001/XMLSchema#string

Robert C Blanks

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

New potassium binders for the treatment of hyperkalemia: current data and opportunities for the future

Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective?

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Mechanism of Action and Pharmacology of Patiromer, a Nonabsorbed Cross-Linked Polymer That Lowers Serum Potassium Concentration in Patients With Hyperkalemia

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.

Management of Hyperkalemia: An Update for the Internist.

Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial.

P304

244-253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1074248417741685

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29130735

http://www.w3.org/2001/XMLSchema#string

P932

5987854

http://www.w3.org/2001/XMLSchema#string